Skip to main content
Log in

Application of Scaling Factors in Simultaneous Modeling of Microarray Data from Diverse Chips

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose

Microarrays have been utilized in many biological, physiological and pharmacological studies as a high-throughput genomic technique. Several generations of Affymetrix GeneChip® microarrays are widely used in gene expression studies. However, differences in intensities of signals for different probe sets that represent the same gene on various types of Affymetrix chips make comparison of datasets complicated.

Materials and Methods

A power coefficient scaling factor was applied in the pharmacokinetic/pharmacodynamic (PK/PD) modeling to account for differences in probe set sensitivities (i.e., signal intensities). Microarray data from muscle and liver following methylprednisolone 50 mg/kg i.v. bolus and 0.3 mg/kg/h infusion regimens were taken as an exemplar.

Results

The scaling factor applied to the pharmacodynamic output function was used to solve the problem of intensity differences between probe sets. This approach yielded consistent pharmacodynamic parameters for the applied models.

Conclusions

Modeling of pharmacodynamic/pharmacogenomic (PD/PG) data from diverse chips should be performed with caution due to differential probe set intensities. In such circumstances, a power scaling factor can be applied in the modeling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

ADX:

adrenalectomized

BS:

biosignal

CS:

corticosteroids

CV:

coefficient of variation

DR(N):

nucleus drug-receptor complex

GR:

glucocorticoid receptor

GRE:

glucocorticoid response element

MPL:

methylprednisolone

PD:

pharmacodynamics

PG:

pharmacogenomics

PK:

pharmacokinetics

References

  1. J. Y. Jin, R. R. Almon, D. C. DuBois, and W. J. Jusko. Modeling of corticosteroid pharmacogenomics in rat liver using gene microarrays. J. Pharmacol. Exp. Ther. 307:93–109 (2003).

    Article  PubMed  CAS  Google Scholar 

  2. Y. N. Sun, D. C. DuBois, R. R. Almon, and W. J. Jusko. Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver. J. Pharmacokinet. Biopharm. 26:289–317 (1998).

    Article  PubMed  CAS  Google Scholar 

  3. Y. N. Sun, L. I. McKay, D. C. DuBois, W. J. Jusko, and R. R. Almon. Pharmacokinetic/Pharmacodynamic models for corticosteroid receptor down-regulation and glutamine synthetase induction in rat skeletal muscle by a Receptor/Gene-mediated mechanism. J. Pharmacol. Exp. Ther. 288:720–728 (1999).

    PubMed  CAS  Google Scholar 

  4. R. Ramakrishnan, D. C. DuBois, R. R. Almon, N. A. Pyszczynski, and W. J. Jusko. Pharmacodynamics and pharmacogenomics of methylprednisolone during 7-day infusions in rats. J. Pharmacol. Exp. Ther. 300:245–256 (2002).

    Article  PubMed  CAS  Google Scholar 

  5. R. R. Almon, J. Chen, G. Snyder, D. C. DuBois, W. J. Jusko, and E. P. Hoffman. In vivo multi-tissue corticosteroid microarray time series available online at Public Expression Profile Resource (PEPR). Pharmacogenomics 4:791–799 (2003).

    Article  PubMed  CAS  Google Scholar 

  6. R. R. Almon, D. C. DuBois, W. H. Piel, and W. J. Jusko. The genomic response of skeletal muscle to methylprednisolone using microarrays: tailoring data mining to the structure of the pharmacogenomic time series. Pharmacogenomics 5:525–552 (2004).

    Article  PubMed  CAS  Google Scholar 

  7. R. R. Almon, D. C. Dubois, J. Y. Jin, and W. J. Jusko. Pharmacogenomic responses of rat liver to methylprednisolone: an approach to mining a rich microarray time series. Aaps J. 7:E156–E194 (2005).

    Article  PubMed  CAS  Google Scholar 

  8. R. R. Almon, W. Lai, D. C. DuBois, and W. J. Jusko. Corticosteroid-regulated genes in rat kidney: mining time series array data. Am. J. Physiol. 289:E870–E882 (2005).

    CAS  Google Scholar 

  9. Y. Dong, L. Poellinger, J. A. Gustafsson, and S. Okret. Regulation of glucocorticoid receptor expression: evidence for transcriptional and posttranslational mechanisms. Mol. Endocrinol. 2:1256–1264 (1988).

    Article  PubMed  CAS  Google Scholar 

  10. D. Z. D’Argenio and A. Schumitzky. ADAPT II user’s guide: pharmacokinetic/pharmacodynamic systems analysis software, Biomedical Simulation Resource, Los Angeles, 1997.

    Google Scholar 

  11. Technical note: array design and performance of the genechip rat expression set 230. http://www.affymetrix.com/support/technical/technotesmain.affx.

Download references

Acknowledgments

We would like to acknowledge Ms Nancy Pyszczynski for the conduct of animal studies. This work was supported by grants GM24211 and GM67650 from the National Institute of General Medical Sciences, National Institutes of Health, in part by grant R24HD050846 from NICHD National Center for Medical Rehabilitation Research and a research grant from NASA.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William J. Jusko.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yao, Z., Zhao, B., Hoffman, E.P. et al. Application of Scaling Factors in Simultaneous Modeling of Microarray Data from Diverse Chips. Pharm Res 24, 643–649 (2007). https://doi.org/10.1007/s11095-006-9215-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-006-9215-y

Key words

Navigation